The healthcare sector is showing resilience, with a 15% year-to-date gain making it a favored safe haven. CVS Health Corp. is identified as a stock with strong breakout potential, supported by technical indicators.
Analysts suggest a key level between $82-$86 for CVS Health, with targets of $99 and potentially $150 in the long term if current trends continue.
CVS Health Poised for Long-Term Breakout as Healthcare Sector Shines
The healthcare sector is currently experiencing a significant surge, acting as a safe haven for investors amidst turbulent market conditions. Year-to-date, the sector has seen a robust 15% increase, with many of its key components presenting attractive risk-reward opportunities. Among these, CVS Health Corp. stands out, with its stock chart signaling a potential long-term breakout.
CVS Health: A Closer Look at the Chart
According to Jay Woods, Chief Market Strategist at Freedom Capital Markets, CVS Health presents a compelling investment case. Woods highlights a critical support and resistance level between $82 and $86 on the one-year daily chart. This level serves as a key indicator: staying long above it suggests a continuation of the positive trend, while falling below it warrants re-evaluation.
Key Short-Term Indicators for CVS Health:
- Support has held firm.
- The near-term downtrend has been broken.
- Momentum indicators are turning upward, with a MACD buy signal.
- A target of $99 is identified, which would fill the gap from its last earnings report.
- Further momentum could push the price to $105, challenging 52-week highs.
Long-Term Outlook for CVS Health
Examining a five-year weekly chart reinforces the short-term thesis and points towards a significant long-term breakout. Woods sees potential price targets reaching $150 over the next 6 to 9 months.
Key Long-Term Indicators for CVS Health:
- A new, sustained long-term uptrend is forming.
- The critical risk management level of $82 to $86 remains consistent across timeframes.
- A long-term Stochastic buy signal has been triggered, while other momentum indicators are neutral.
- Initial targets are set at $110, with a probable retest of resistance.
- A breakout above $110 could unlock upside potential to $150 within 6 to 9 months.
Jay Woods emphasizes that this analysis is for informational purposes only and does not constitute financial advice. Investors are encouraged to conduct their own research and consult with a financial advisor before making investment decisions.
Disclosure: Jay Woods owns JPMorgan personally and with family. All opinions expressed are solely his own and do not reflect the views of CNBC.
